Source:http://linkedlifedata.com/resource/pubmed/id/15194430
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2004-6-14
|
pubmed:abstractText |
The c-Myb transcription factor plays a central role in the regulation of cell growth and differentiation of hematopoietic cells. Being the product of a proto-oncogene, one would expect c-Myb function to be modulated by signal transduction pathways, but our knowledge on such regulation of c-Myb is rather limited. Recently, we and others showed that c-Myb is subjected to sumoylation and that this posttranslational modification has considerable effect on c-Myb's activity. Interestingly, many proteins subjected to SUMO-1 conjugation associate with the promyelocytic leukemia (PML) protein and localize to PML nuclear bodies (PML NBs). Although the precise molecular function of PML NBs still remains to be defined, they seem to play a role in regulation of gene expression and are linked to specific cellular signaling. We show here that c-Myb localizes to PML NBs and that c-Myb interacts with PML as judged by immunofluorescence microcopy and co-immunoprecipitation experiments. Enforced expression of PML IV was shown to enhance c-Myb-dependent reporter activation. Our results imply a role for PML and possibly other components of PML NBs in regulating c-Myb's activity. This novel link between c-Myb and PML, two gene products being implicated in leukemic disorders, suggests that previously unknown mechanisms for regulating c-Myb's activity involving PML may exist.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Nuclear Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-myb,
http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0014-4827
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
297
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
118-26
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15194430-Animals,
pubmed-meshheading:15194430-Cell Line,
pubmed-meshheading:15194430-Cell Nucleus Structures,
pubmed-meshheading:15194430-Cercopithecus aethiops,
pubmed-meshheading:15194430-Fluorescent Antibody Technique,
pubmed-meshheading:15194430-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:15194430-Genes, Reporter,
pubmed-meshheading:15194430-Hematopoiesis,
pubmed-meshheading:15194430-Hematopoietic Stem Cells,
pubmed-meshheading:15194430-Leukemia,
pubmed-meshheading:15194430-Neoplasm Proteins,
pubmed-meshheading:15194430-Nuclear Proteins,
pubmed-meshheading:15194430-Proto-Oncogene Proteins c-myb,
pubmed-meshheading:15194430-Transcription Factors,
pubmed-meshheading:15194430-Tumor Suppressor Proteins,
pubmed-meshheading:15194430-Up-Regulation
|
pubmed:year |
2004
|
pubmed:articleTitle |
c-Myb associates with PML in nuclear bodies in hematopoietic cells.
|
pubmed:affiliation |
Department of Molecular Biosciences, University of Oslo, Blindern, N-0316 Oslo, Norway.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|